Advancements and Projections in the Ophthalmic Devices Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew ...

Vision Care Returns to Growth: Within Vision Care, Alcon is registering solid growth, banking on strong sales of its contact lenses and ocular health products. In contact lenses, Alcon ...

Cooper’s pricing power and cost optimization efforts are expected to drive margin expansion. Read why I reiterate a Buy ...

In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

J.P. Morgan analyst David Adlington maintained a Buy rating on Gerresheimer (0NTI – Research Report) today and set a price target of ...

The Switzerland market ended on a bright note on Monday with stocks holding early gains thanks to sustained buying right through the day's session. Investors digested the nation's ...

Edetate disodium (EDTA) is a chelating agent used in a variety of nonophthalmic products, including hair ... Polyquad was formulated in the mid 1980s by Alcon as a preservative for contact lens ...

Johnson & Johnson (NYSE: JNJ) expanded the rollout of its latest Tecnis Odyssey presbyopia-correcting intraocular lenses ...

Medical device peers Alcon, Cooper Cos. and Johnson & Johnson own 25% to 40% of the market for contact lenses vs. 10% for Bausch + Lomb. In pharmaceuticals, AbbVie would encounter antitrust ...

when he signed an appointment of eight members of a 12-person panel that considered approval of a lens implant by Alcon, an eye care drug and device maker and a client of Ms. Shuren’s.

Even in areas of tech that have done better, bosses note that the war is undermining morale and productivity. What is more, ...